Piperazine derivatives

Details Piperazine derivatives Piperazine derivatives

2006-08-29

2006-08-29

Bernhardt, Emily (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S253130, C514S254010, C514S254020, C514S254050, C514S255010, C544S295000, C544S365000, C544S369000, C544S372000, C544S391000, C544S366000

Reexamination Certificate

active

07098212

ABSTRACT:
The present invention relates to compounds of the formula Iand the pharmaceutically acceptable forms thereof; wherein X, Y, a, b, c, d, R1, R2, R3, R4and R5are as defined herein. Moreover, the present invention is also directed at pharmaceutical compositions comprising a compound of the formula I and a pharmaceutically acceptable carrier. Furthermore, the present invention is directed at methods of using the herein described compounds and compositions for treating or preventing a disorder or condition that can be treated or prevented by antagonizing the CCR1 receptor in a mammal.

REFERENCES:
patent: 3119742 (1964-01-01), Heimlich et al.
patent: 3492397 (1970-01-01), Peters et al.
patent: 3538214 (1970-11-01), Polli et al.
patent: 4060598 (1977-11-01), Groppenbächer et al.
patent: 4173626 (1979-11-01), Dempski et al.
patent: 5607930 (1997-03-01), Long et al.
patent: 5780472 (1998-07-01), Cho et al.
patent: 6207665 (2001-03-01), Bauman et al.
patent: 6649611 (2003-11-01), Blumberg et al.
patent: 2002/0119961 (2002-08-01), Blumberg et al.
patent: WO 9501343 (1995-01-01), None
patent: WO 9856771 (1998-12-01), None
patent: WO 0172728 (2001-10-01), None
patent: WO 0236581 (2002-05-01), None
Trivedi et al. Annual Reports in Medicinal Chemistry, vol. 35, p. 191-200 (2000).
Combadiere et al. J. Biol. Chem., 270 (50) 29671-29675, 1995.
Teran et al., J. Immunol., 1806-1812, 1996.
Smith et al., J. Immunol, 153, 4704, 1994.
Cook et al., Science, 269, 1583, 1995.
Belperio et al., J. Immunol., 165, 461, 2000.
Gao et al., J. Clin Invest, 105, 35, 2000.
Rottman et al., Eur. J. Imm, 30, 2372, 2000.
Kuna et al., J. Allergy Clinical Immunology, (1994), Abstract 321.
Maryanoff et al., Journal of American Chemical Society, (1985), vol. 107, pp. 217-226.
Giasl et al., Helvetica Chimica Acta, (1997), vol. 80, pp. 671-683.
LeBerre et al., Bulletin De La Société Chimique France, (1975), N° 150, pp. 807-811.
Boros et al., Synthetic Communications, (2001), vol. 31, No. 4, pp. 505-510.
Cignarella et al, Eur. J. Med. Chem., (1990), vol. 25, pp. 749-756.
Merck Index, 13thed., Merck & Co., vol. 201, p. 772, Fipexide, No. 4114.

Affiliated with

Also associated with

Rating

Piperazine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Piperazine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazine derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3696247